Interpace Biosciences, Inc. (Nasdaq: IDXG) today announced acceptance of the first manuscript reporting the clinical performance of the company’s ThyGeNEXT® and ThyraMIR® tests in the Journal of the American Society of Cytopathology. The article, entitled “Clinical performance of multiplatform mutation panel and microRNA risk classifier in indeterminate thyroid nodules”, will be published online in the …
Interpace Biosciences, Inc. (IDXG) announced today that its agreement with LabCorp® (LH) has been extended for an additional two years, through January 2022. Interpace and LabCorp initially entered in to their collaboration in 2016 through which LabCorp became the first national laboratory in the U.S. to offer electronic ordering and result reporting for Interpace’s proprietary …
The dietary supplement industry now has a state-of-the-art solution for ensuring supply chain transparency and reassuring consumers that what’s listed on an ingredient panel is actually in their product. As a developer of patented and trademarked ingredients, Nutrition21 has introduced this solution with the adoption of CertainT, which is designed to protect the intellectual property …
Interpace Biosciences, Inc. (Nasdaq: IDXG) today announced that the Center for Medicare and Medicaid Services (CMS) has modified the reimbursement for Interpace Diagnostics’ ThyraMIR® miRNA classifier for evaluating indeterminate thyroid nodules retroactively to January 1, 2020. This determination increases the Medicare reimbursement for ThyraMIR® from approximately $1800 to $3000 reflecting a re-evaluation of the technical …
Onkos Surgical® is pleased to announce the launch of GenVie™ Magnesium Bone Scaffold, a novel biologic technology that further expands Onkos’ reach in complex limb salvage procedures. GenVie is the first 510(k) cleared magnesium-based bone void filler in the orthopaedic marketplace and is available via a private label distribution agreement with Bone Solutions Inc. (OsteoCrete®) …
Centurion Service Group, a leader in medical equipment solutions, announced today that it has acquired Salt Lake City, UT Monet Medical, an advanced refurbisher of best-in-class beds, stretchers, infusion pumps and other medical equipment with strong ties to major national medical distributors. Originally a medical equipment auction house, Centurion Service Group has firmly cemented its …
Biocoat, Inc., a specialty manufacturer of hydrophilic biomaterial coatings for medical devices, today announced the launch of HYDAK® UV. The new version of its original HYDAK® coating is designed to be cured using ultraviolet (UV) light, allowing for flexible integration with industry standard UV coating systems. The innovative coating is built on the proven bi-laminar …
Interpace Biosciences , Inc. (NASDAQ: IDXG) (“Interpace”) a leader in enabling personalized medicine, is pleased to announce today that Ron Rocca, President & CEO of Exagen, Inc. (NASDAQ: XGN) has been appointed to the Interpace Board of Directors. Ron has significant experience as a senior executive at companies which develop and market high value, proprietary …
Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced the pricing of an underwritten public offering of 1,625,000 shares of its common stock at a price to the public of $18.50 per share. The gross proceeds from this …
Greenbrook TMS NeuroHealth Centers, one of the leading providers of Transcranial Magnetic Stimulation (TMS) therapy in the United States, announced today that it is now offering BrainsWay’s Deep TMS therapy for patients with obsessive-compulsive disorder (OCD) at its Greenbrook – Cary facility in North Carolina.